Professor, Pathology, University of Arizona College of Medicine
Pathology
Dr. Lisa M. Rimsza, MD
|
|
Give Review
Lisa Rimsza is an expert in the field of Pathology. He went to medical school at University of Arizona College of Medicine - Tucson. University of Arizona College of Medicine - Tucson is ranked 67 in research and 42 in primary care medicine Lisa Rimsza has written publications. He has 101 publications published with PubMed. The lastest publication is: 'The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy.'
Publications
- Survival of human Lymphoma cells requires B-cell receptor engagement by self-antigens.
- Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression.
- Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell Lymphoma: SWOG S0601.
- Indolent Lymphoma: follicular Lymphoma and the microenvironment-insights from gene expression profiling.
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggresive B-cell Lymphoma.
- BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymph...
- Loss of signalling via Gα13 in germinal centre B-cell-derived Lymphoma.
- Phase II study of imexon, a pro-oxidant molecule, in relapsed and refractory B-cell non-Hodgkin Lymphoma.
- Clinical Significance of MYC Expression and/or "High-grade" Morphology in Non-Burkitt, Diffuse Aggressive B-cell Lymphomas: A SWOG S9704 Correlative Study.
- Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin Lymphoma.
- Gene expression signatures delineate biologic and prognostic subgroups in peripheral T-cell Lymphoma.
- A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP-Rituximab versus CHOP + 131Iodine--Tositumomab.
- Autologous transplantation as consolidation for aggressive non-Hodgkin's Lymphoma.
- Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell Lymphoma.
- Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell Lymphoma.
- Genome-wide copy number analyses reveal genomic abnormalities involved in transformation of follicular Lymphoma.
- A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell Lymphoma: Role of cyclin-dependent kinase inhibitors.
- A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell Lymphoma; SWOG 0213.
- Related F-box proteins control cell death in Caenorhabditis elegans and human Lymphoma.
- Copper Chelator ATN-224 Induces Peroxynitrite-Dependent Cell Death in Hematological Malignancies.
- Colorimetric In Situ Hybridization Identifies MYC Gene Signal Clusters Correlating With Increased Copy Number, mRNA, and Protein in Diffuse Large B-Cell Lymphoma.
- Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus 131Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin...
- Developmental differences in megakaryocyte size in infants and children.
- A phase II trial of standard dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffus...
- Lack and/or aberrant localization of major histocompatibility Class II (MHCII)protein in plasmablastic Lymphoma.
- Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell Lymphoma.
- MicroRNA profiles of t(14;18)-negative follicular Lymphoma support a late germinal center B-cell phenotype.
- BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-Cell Lymphoma Treated with CHOP-like therapy and Rituximab.
- A Phase 2 Study of Vorinostat for Treatment of Relapsed or Refractory Hodgkin Lymphoma: Southwest Oncology Group Study S0517.
- Classification of Diffuse Large B cell Lymphoma into Germinal Center and Activated B cell Subtypes Using a Nuclease Protection Assay on Paraffin Embedded Tissues.
- A strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell Lymphoma.
- Cooperative epigenetic modulation by cancer amplicon genes.
- Pathway discovery in mantle cell Lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.
- Tumor-associated macrophages and survival in classic Hodgkin's Lymphoma.
- A new immunostain algorithm classifies diffuse large B-cell Lymphoma into molecular subtypes with high accuracy.
- Follicular Lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
- Regions of acquired uniparental disomy at diagnosis of follicular Lymphoma are associated with both overall survival and risk of transformation.
- Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell Lymphoma treated with R-CHOP.
- The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to Disease progression and poorer overal...
- Effects of sepsis on neonatal thrombopoiesis.
- Molecular subtypes of diffuse large B-cell Lymphoma arise by distinct genetic pathways.
- Oncogenic CARD11 mutations in human diffuse large B cell Lymphoma.
- Frequent occurrence of deletions in primary mediastinal B-cell Lymphoma.
- Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell Lymphoma.
- Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates.
- Follicular Lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.
- Umbilical cord blood produces small megakaryocytes after transplantation.
- Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell Lymphoma into germinal center B-cell and nongerminal center B-cell subtyp...
- Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes.
- Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell Lymphoma is highly coordinated and related to poor patient su...
- Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell Lymphoma is highly coordinated and not due to chromosomal delet...
- A redox signature score identifies diffuse large B-cell Lymphoma patients with a poor prognosis.
- Severe thrombocytopenia in a neonate with congenital HIV infection.
- CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell Acute lymphoblastic leu...
- Reticulated platelet percentages in term and preterm neonates.
- Prediction of survival in follicular Lymphoma based on molecular features of tumor-infiltrating immune cells.
- A neonate with severe thrombocytopenia and radio-ulnar synostosis.
- Pseudothrombocytopenia in a preterm neonate.
- Loss of MHC class II gene and protein expression in diffuse large B-cell Lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless...
- AML, angiogenesis, and prognostic variables.
- Natural killer-like T-cell Lymphoma of the parotid in a patient infected with human immunodeficiency virus.
- Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell Lymphoma.
- Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.
- Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as models.
- SOX11 expression is highly specific for mantle cell Lymphoma and identifies the cyclin D1-negative subtype.
- Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell Lymphoma: an international collaborative study.
- ALK- anaplastic large-cell Lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell Lymphoma, not otherwise specified: repor...
- Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell Lymphoma.
- Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymph...
- Regulating the suppressors: helpful or harmful?
- Diffuse aggressive histologies of non-hodgkin lymphoma: treatment and biology of limited Disease.
- Cyclin D1-negative mantle cell Lymphoma: a clinicopathologic study based on gene expression profiling.
- Efficacy of lenalidomide in Myelodysplastic syndromes.
- Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic Leukemia.
- Endothelial stimulation by small lymphocytic Lymphoma correlates with secreted levels of basic fibroblastic growth factor.
- Erdheim-Chester Disease: case report, PCR-based analysis of clonality, and review of literature.
- High microvessel density determines a poor outcome in patients with diffuse large B-cell Lymphoma treated with rituximab plus chemotherapy.
- Enteropathy-associated T-cell Lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project.
- Frequent mutation of histone-modifying genes in non-Hodgkin Lymphoma.
- IgH PCR of zinc formalin-fixed, paraffin-embedded non-Lymphomatous gastric samples produces artifactual "clonal" bands not observed in paired tissues unexposed to zinc...
- Treatment of refractory Acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomeras...
- Developmental changes in the expression of transcription factors GATA-1, -2 and -3 during the onset of human medullary haematopoiesis.
- Mechanisms underlying thrombocytopenia in the neonatal intensive care unit.
- Effects of anoxia on megakaryocyte progenitors derived from cord blood CD34pos cells.
- Benign B-cell precursors (hematogones) are the predominant lymphoid population in the bone marrow of preterm infants.
- Pathological cases of the month. Lymphomatoid granulomatosis.
- Rapid automated combined in situ hybridization and immunohistochemistry for sensitive detection of cytomegalovirus in paraffin-embedded tissue biopsies.
- The presence of CD34+ cell clusters predicts impending relapse in children with Acute lymphoblastic leukemia receiving maintenance chemotherapy.
- The major vault protein (MVP), a new multidrug resistance associated protein, is frequently expressed in multiple Myeloma.
- A bone marrow biopsy technique suitable for use in neonates.
- Microsatellite instability is not a defining genetic feature of Acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of ...
- Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage Acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion...
- A practical approach to evaluating and treating Neutropenia in the neonatal intensive care unit.
- Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit.
- Congenital autoimmune Neutropenia in two premature neonates.
- The diagnosis of hairy cell Leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
- Effects of hypoxia on megakaryocyte progenitors obtained from the umbilical cord blood of term and preterm neonates.
- Molecular diagnosis of Burkitt''s Lymphoma.
- HLA-DR protein status predicts survival in patients with diffuse large B-cell Lymphoma treated on the MACOP-B chemotherapy regimen.
- Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell Lymphoma: Southwest Oncology Gr...
Schools
University of Arizona
University Of Az College Of Med
University Of Nm School Of Med
Conditions Treated
- Acute Leukemia
- Anemia
- Hodgkin's Disease
- Leukocytosis
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
- American Republic
- Cigna HMO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Employer Group PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Humana
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
- United Healthcare
Education
-
University of New Mexico -
University of Arizona -
University of Arizona College of Medicine - Tucson
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477623023 |
| Last Name Of The Provider | RIMSZA |
| First Name Of The Provider | LISA |
| View All |
Similar Doctors
|
|
Dr. Paul R. Vanatta, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas M. Grogan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald P. Spark, MD |
|
|
Dr. Jennifer Thorn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George E. Wilcox II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pavani Chalasani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan L. Pekarske, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher C. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brad E. Wheeler, MD
This Doctor is OpenDoctor Recommended.
|